Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

No evidence for mutagenic effects of ribavirin: report of two normal pregnancies.

Hegenbarth K, Maurer U, Kroisel PM, Fickert P, Trauner M, Stauber RE.

Am J Gastroenterol. 2001 Jul;96(7):2286-7. No abstract available.

PMID:
11467687
2.

Paternal use of ribavirin-interferon alpha 2B combination therapy before conception.

Taguchi N, Ito S.

Can Fam Physician. 2005 Dec;51:1623-5. Review.

3.

Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C--a case report and review of the literature.

Bolukbas C, Bolukbas FF, Kebdir T, Canayaz L, Dalay AR, Kilic G, Ovunc O.

Acta Gastroenterol Belg. 2005 Oct-Dec;68(4):432-4. Review.

PMID:
16432996
4.

Peginterferon and ribavirin for chronic hepatitis C.

Hoofnagle JH, Seeff LB.

N Engl J Med. 2006 Dec 7;355(23):2444-51. Review. No abstract available.

PMID:
17151366
6.

Side effects of medical therapy for chronic hepatitis C.

Shiffman ML.

Ann Hepatol. 2004 Jan-Mar;3(1):5-10. Review.

PMID:
15118573
7.

Side effects of therapy for chronic hepatitis C.

Russo MW, Fried MW.

Gastroenterology. 2003 May;124(6):1711-9. Review. No abstract available.

PMID:
12761728
8.

Fatal cardiomyopathy associated with pegylated interferon/ribavirin in a patient with chronic hepatitis C.

Condat B, Asselah T, Zanditenas D, Estampes B, Cohen A, O'Toole D, Bonnet J, Ngo Y, Marcellin P, Blazquez M.

Eur J Gastroenterol Hepatol. 2006 Mar;18(3):287-9. Review.

PMID:
16462543
9.

Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C.

Wendling J, Descamps V, Grossin M, Marcellin P, Le Bozec P, Belaich S, Crickx B.

Arch Dermatol. 2002 Apr;138(4):546-7. Review. No abstract available.

PMID:
11939833

Supplemental Content

Support Center